400 results match your criteria Pretibial Myxedema


Successful therapeutic approach in patient with elephantiasic pretibial myxedema.

An Bras Dermatol 2019 Nov 25. Epub 2019 Nov 25.

Graduate and Post-Graduate Program in Dermatology, Faculdade Suprema, Juiz de Fora, MG, Brazil; Work Performed in the Dermatological Research Center of HU-CAS Ebserh, Hospital Universitário da Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.

Localized pretibial myxedema is a dermopathy whose treatment is a challenge in dermatology, occurring in 0.5-4% of patients with Graves' disease. This autoimmune thyroid condition stimulates the production of hyaluronic acid (HA) and glycosaminoglycans (GAG) that are deposited particularly in the pretibial region. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.abd.2019.02.007DOI Listing
November 2019

Elephantiasic Pretibial Myxedema with Graves' Disease: Spontaneously Induced and Dramatically Resolved after Radioiodine Treatment.

Eur Thyroid J 2020 Jan 14;9(1):55-56. Epub 2019 Nov 14.

Department of Nuclear Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000504217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024891PMC
January 2020

Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy.

Best Pract Res Clin Endocrinol Metab 2020 Jan 4;34(1):101388. Epub 2020 Feb 4.

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Electronic address:

Graves' disease (GD) is characterized by thyrotoxicosis, caused by the presence of circulating thyroid stimulating antibodies (TSAb), that are determinant also in the pathogenesis of its extrathyroidal manifestations [Graves' ophthalmopathy (GO), pretibial myxedema]. T helper (Th)1 immune response prevails in the immune-pathogenesis of GD and GO, during the active phase, when Th1 chemokines, and their (C-X-C)R3 receptor, play a key role. In GD, the existing treatments are not ideal for hyperthyroidism (long-term remission with anti-thyroid-drugs only in 50% of patients; while radioiodine and surgery cause hypothyroidism). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beem.2020.101388DOI Listing
January 2020

A Case of Unilateral Dermopathy Possibly Related to Graves' Disease.

Eur Thyroid J 2019 Oct 11;8(5):278-282. Epub 2019 Jun 11.

Department of Clinical and Experimental Medicine, Endocrinology Units, University of Pisa and University Hospital of Pisa, Pisa, Italy.

Background: The pathogenesis of the extrathyroidal manifestations of Graves' disease (GD) is not fully clarified. According to the most common hypothesis, they would reflect an autoimmune reaction against antigens constitutively expressed by the thyroid and by the extrathyroidal affected tissues. According to another hypothesis, the so-called Kriss' hypothesis, soluble autoantigens released from the thyroid would reach the affected tissues, where they would become the target of the immune system. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000500297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873008PMC
October 2019

Severe pretibial myxedema refractory to systemic immunosuppressants.

Cutis 2019 Sep;104(3):E1-E3

University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
September 2019

Hypothyroidism to Graves' disease and late appearance of pretibial myxoedema.

Lancet 2019 Oct;394(10206):1364

Department of Internal Medicine, OLVG East, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)32281-0DOI Listing
October 2019
1 Read

Image Gallery: Nodular pretibial myxoedema.

Authors:
J-W Liu D-L Ma

Br J Dermatol 2019 11 24;181(5):e117. Epub 2019 Jul 24.

Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.18241DOI Listing
November 2019
3 Reads

[Pretibial myxedema: pathogenetic features and clinical aspects].

Probl Endokrinol (Mosk) 2019 06 30;65(2):134-138. Epub 2019 Jun 30.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology.

Pretibial myxedema (PTM) or thyroid dermopathy is a rare extrathyroidal manifestation of Graves' disease. The condition is accompanied by mucinous skin changes, mainly in the anterior tibial surface. Severe forms may lead to lymphatic congestion and disability. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14341/probl9848DOI Listing
June 2019
4 Reads

Thyroxine-Induced Preradial Myxedema.

Indian Dermatol Online J 2019 Mar-Apr;10(2):162-164

Department of Skin and STD, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Mawdiangdiang, Shillong, Meghalaya, India.

Localized myxedema is most commonly described in patients with hyperthyroidism, especially Graves' disease. Although pretibial myxedema generally appears as indurated plaques on the shins, it has also been rarely reported in other areas such as the face, shoulders, arms, and abdomen. We report a rare case of preradial myxedema in a hyperthyroid patient who was taking thyroxine post thyroidectomy for goiter. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/idoj.IDOJ_161_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434759PMC
April 2019
7 Reads

Electrosurgical debulking of pretibial myxedema of the foot.

Dermatol Online J 2019 Feb 15;25(2). Epub 2019 Feb 15.

Department of Dermatology, Mount Sinai Hospital, New York City, New York.

Pretibial myxedema or thyroid dermopathy constitutes dermal deposition of mucin, primarily hyaluronic acid and chondroitin sulfate. It is a manifestation of autoimmune thyroiditis, seen more in Graves disease than in Hashimoto thyroiditis. The time delay from treatment of hyperthyroidism to appearance of localized myxedema varies from one month to 16 years (mean 5. Read More

View Article

Download full-text PDF

Source
February 2019
14 Reads

Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case Series.

Thyroid 2019 05 8;29(5):692-699. Epub 2019 Apr 8.

1 Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.

Severe pretibial myxedema (PTM) can be difficult to manage, highlighting the need to investigate newer therapies. Rituximab (RTX) and intravenous immunoglobulin (IVIg) have been tried in Graves' orbitopathy. Since PTM and orbitopathy share a similar underlying pathophysiology, this study aimed to explore these therapies for progressive PTM. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2018.0706DOI Listing
May 2019
21 Reads

[Pretibial myxoedema in Graves' disease].

Aten Primaria 2019 12 4;51(10):654-655. Epub 2019 Mar 4.

Departamento de Dermatología, Clínica Universidad de Navarra, Pamplona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.aprim.2018.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930939PMC
December 2019
11 Reads

Intravenous immunoglobulin treatment: Where do dermatologists stand?

Authors:
Selma Emre

Dermatol Ther 2019 05 4;32(3):e12854. Epub 2019 Mar 4.

Department of Dermatology, Yildirim Beyazit University, Medical School, Ankara, Turkey.

Intravenous immunoglobulins (IVIG) are therapeutic products, comprising polyclonal IgGs, which are obtained from human plasma pool of healthy blood donors. Despite the lack of Food and Drug Administration (FDA) approval, the experience of using IVIG in various dermatological diseases increases day by day and exciting results are reported. However, experience with the use of IVIG in dermatological indications are mostly case reports whereas randomized, controlled, double-blind, multicentric studies have not been performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.12854DOI Listing
May 2019
30 Reads

Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature.

World J Clin Cases 2018 Nov;6(14):854-861

Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.

Pretibial myxedema (PTM), an uncommon manifestation of Graves' disease (GD), is a local autoimmune reaction in the cutaneous tissue. The treatment of PTM is a clinical challenge. We herein report on a patient with PTM who achieved complete remission by multipoint subcutaneous injections of a long-acting glucocorticoid and topical glucocorticoid ointment application for a self-controlled study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12998/wjcc.v6.i14.854DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265002PMC
November 2018
25 Reads

Pretibial myxedema.

Med Clin (Barc) 2019 05 15;152(9):375. Epub 2018 Oct 15.

Servicio de Dermatología, Hospital Regional Universitario de Málaga, Málaga, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2018.08.011DOI Listing
May 2019
15 Reads

Pretibial myxedema successfully treated with intralesional hyaluronidase.

JAAD Case Rep 2018 Oct 3;4(9):874-876. Epub 2018 Oct 3.

Department of Dermatology, Mayo Clinic, Jacksonville, Florida.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23525126183022
Publisher Site
http://dx.doi.org/10.1016/j.jdcr.2018.08.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172446PMC
October 2018
13 Reads

[Review through a clinical case of pretibial injuries].

Aten Primaria 2019 03 20;51(3):189-190. Epub 2018 Sep 20.

Medicina Familiar y Comunitaria, Servicio de Urgencias, ICS-Atenció Primària Costa de Ponent, Hospital de Viladecans, Viladecans, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.aprim.2018.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836899PMC

Thyroid dermopathy and acropachy in pediatric patients.

Pediatr Dermatol 2018 Nov 6;35(6):e371-e374. Epub 2018 Sep 6.

George Washington University School of Medicine & Health Sciences, Washington, District of Columbia.

The extrathyroid manifestations of Graves disease (GD) include thyroid orbitopathy, dermopathy, and acropachy. Thyroid dermopathy (TD), also known as pretibial myxedema, classically presents as nonpitting edema or plaquelike lesions on the pretibial region, while thyroid acropachy (TA) is seen in cases of severe TD, characterized by soft tissue swelling and clubbing of fingers and toes, as well as a periosteal reaction of the bones of the hands and feet. Both TD and TA are rare manifestations of thyroid disease and uncommonly reported in pediatric patients. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pde.13670
Publisher Site
http://dx.doi.org/10.1111/pde.13670DOI Listing
November 2018
53 Reads

Pretibial myxedema in a euthyroid patient.

Hormones (Athens) 2018 Mar 17;17(1):133-135. Epub 2018 Apr 17.

Division of Endocrinology, Police Medical Center of Thessaloniki, Monastiriou 326, 54121, Thessaloniki, Greece.

Pretibial myxedema (PM) is a rare extrathyroidal manifestation of Graves' disease (GD), usually during the hyperthyroid state, coexisting with orbitopathy. We describe a rare case of a biopsy-proven PM in a euthyroid patient, without history of GD or Hashimoto's thyroiditis. Assessment of commonly reported thyroid autoantibodies, such as thyroid peroxidase and thyroglobulin autoantibodies, thyroid stimulating immunoglobulins and thyroid binding inhibitory immunoglobulins, was negative. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s42000-018-0008-6
Publisher Site
http://dx.doi.org/10.1007/s42000-018-0008-6DOI Listing
March 2018
69 Reads

Thyrotropin Receptor Antibodies-An Overview.

Ophthalmic Plast Reconstr Surg 2018 Jul/Aug;34(4S Suppl 1):S20-S27

Department of Medicine and Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, U.S.A.

Purpose: Thyroid autoimmunity affects approximately 5% of the population, and its investigation relies heavily on the use of autoantibodies. Thyroid stimulating hormone receptor (TSHR) autoantibodies (TRAb) play a central role in the evaluation of Graves disease (GD), Graves ophthalmopathy (GO) and pretibial myxedema (PTM). However, there is still controversy regarding overall TRAb assay diagnostic accuracy and their prognostic utility. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IOP.0000000000001052DOI Listing
August 2018
13 Reads

Obesity-Associated Lymphedematous Mucinosis: Two Further Cases and Review of the Literature.

Dermatopathology (Basel) 2018 Jan-Mar;5(1):16-20. Epub 2018 Feb 6.

Section of Dermatology, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.

Cutaneous mucinoses are a group of conditions characterized by increased amounts of acid mucin in the dermis. They can be generalized or localized and occur isolated or in the setting of systemic diseases. Obesity-associated lymphedematous mucinosis is a distinct variant of mucinosis occurring in obese patients without any thyroid dysfunction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000486305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920949PMC
February 2018
23 Reads

Graves Disease in Central Ghana: Clinical Characteristics and Associated Factors.

Clin Med Insights Endocrinol Diabetes 2018 21;11:1179551418759076. Epub 2018 Mar 21.

Department of Surgery, Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Background: Graves disease (GD) has increased in prevalence over the past decade in Africa. Despite this, the condition is not well described, especially in sub-Saharan Africa.

Objective: We have described the clinical characteristics and associated factors of GD in a cohort of patients attending a resource-limited setting tertiary hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179551418759076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865516PMC
March 2018
40 Reads

Response to topical halcinonide following fractional carbon dioxide laser pretreatment in a pretibial myxedema patient.

Indian J Dermatol Venereol Leprol 2018 Nov-Dec;84(6):763

Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijdvl.IJDVL_796_16DOI Listing
January 2019
12 Reads

Dermatologic manifestations of endocrine disorders.

Transl Pediatr 2017 Oct;6(4):300-312

The Ohio State University College of Medicine, Columbus, OH, USA.

The skin serves as a window for clinicians to understand, diagnose, and monitor endocrine disease. Dermatologic manifestations of endocrinopathies contribute significantly to an individual's health and quality of life. In this review, we outline various disorders of the hypothalamic-pituitary axis, thyroid gland, pancreas, adrenal gland, and androgen axis as well as hereditary endocrine syndromes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tp.2017.09.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682371PMC
October 2017
54 Reads

Pretibial myxoedema without thyroid associated orbitopathy in a patient with Graves' disease.

Postgrad Med J 2018 04 18;94(1110):236. Epub 2017 Nov 18.

Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/postgradmedj-2017-135345DOI Listing
April 2018
17 Reads

Treatment of pretibial myxedema with intralesional immunomodulating therapy.

Ther Clin Risk Manag 2017 8;13:1189-1194. Epub 2017 Sep 8.

Department of Endocrinology and Nephrology, Chongqing Emergency Medical Hospital (The Fourth People's Hospital of Chongqing).

Objective: Local immune regulation therapy has been one of the therapeutic methods used for the treatment of autoimmune thyroid disease in patients with pretibial myxedema (PTM). However, the poor response rate and high recurrence rate are still major problems. Whether a premixed corticosteroid, compound betamethasone, could enhance remission rate and decrease recurrence rate in patients with PTM was investigated in the present study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/TCRM.S143711DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598751PMC
September 2017
58 Reads

Elephantiasic Pretibial Myxedema with Involvement of the Buttocks and Face.

Chin Med J (Engl) 2017 Aug;130(15):1887-1888

Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy Medical Sciences, Beijing 100730, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0366-6999.211558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547847PMC
August 2017
23 Reads

Pretibial Myxedema Masquerading as a Venous Leg Ulcer.

Wounds 2017 Mar;29(3):77-79

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL.

The authors report a case of pretibial myxedema (PTM) masquerading as a venous leg ulcer to alert wound care clinicians to this diagnostic possibility. Pretibial myxedema is a localized form of mucin cutaneous deposition characterized by indurated plaques most commonly on anterior legs. It is more likely to present in patients with Graves' disease, but it can be found in euthyroid patients as well. Read More

View Article

Download full-text PDF

Source
March 2017
14 Reads

[Epidemiological, clinical, therapeutic and evolutive aspects of Basedow-Graves disease in the Depatment of Internal Medicine at CHU Aristide Le Dantec, Dakar (Senegal)].

Pan Afr Med J 2016 14;25. Epub 2016 Sep 14.

Médecine Interne, Centre Hospitalier Universitaire Aristide Le Dantec, Dakar, Sénégal.

Basedow-Graves disease is an autoimmune affection characterized by the association of thyrotoxicosis with variable frequency events such as goiter, ophthalmopathy and pretibial myxedema. Its diagnosis is often easy, while its management remains difficult. A simple medical treatment exposes patient to recurrence risk. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11604/pamj.2016.25.6.7868DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268789PMC
March 2017
43 Reads

Annularly arranged nodular pretibial myxedema after 7-year treatment of Graves' disease.

J Dermatol 2018 Jan 2;45(1):110-111. Epub 2017 Feb 2.

Department of Dermatology, Kansai Medical University, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.13750DOI Listing
January 2018
39 Reads

Pretibial myxoedema: a case report with scanning electron microscopy.

J Eur Acad Dermatol Venereol 2017 May 28;31(5):e265-e267. Epub 2016 Oct 28.

Laboratory of Electron Microscopy, Embrapa Clima Temperado (Brazilian Agricultural Research Corporation), Pelotas, Brazil.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jdv.14006
Publisher Site
http://dx.doi.org/10.1111/jdv.14006DOI Listing
May 2017
11 Reads

Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases.

J Thyroid Res 2016 25;2016:2652174. Epub 2016 Aug 25.

Department of Dermatology, China National Nuclear Corporation (CNNC) 416 Hospital, No. 4 Er Huan Lu Bei Si Duan, Chengdu, Sichuan 610051, China.

Background. Pretibial myxedema (PTM) is a rare dermopathy. The morphologic features and mechanism of its evolving process are not reported in large case series. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/2652174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014960PMC
September 2016
33 Reads

Injected Hyaluronidase Reduces the Volume of Exogenous Hyaluronate Fillers in Mice and Results in Clinical Improvement in a Patient with Pretibial Myxedema.

Dermatopathology (Basel) 2016 Jul-Sep;3(3):61-7. Epub 2016 Jul 6.

Department of Dermatology, University Hospital of Geneva, University of Geneva, Geneva, Switzerland.

Background: Hyaluronidases are essential for the breakdown of hyaluronate (HA) in tissues and may be used to prevent the adverse effects of HA fillers.

Objectives: We explored the effect of hyaluronidase on exogenous and endogenous HA in vitro and in vivo.

Materials And Methods: HA fillers were incubated with different concentrations of hyaluronidase and visualized by electrophoresis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000446699DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965543PMC
August 2016
33 Reads

Polypoid and fungating form of elephantiasic pretibial myxedema with involvement of the hands.

Int J Dermatol 2016 Jul 12;55(7):e413-5. Epub 2016 Feb 12.

Department of Dermatology, University of Trieste, Trieste, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.13259DOI Listing
July 2016
33 Reads

Shortness of Breath and Lower Limb Edema in a 54-Year-Old Woman, Is There Any Cure?

Res Cardiovasc Med 2016 Feb 9;5(1):e30549. Epub 2015 Dec 9.

Second Department of Cardiology, Attikon University Hospital, University of Athens, Athens, Greece.

Introduction: Pulmonary hypertension is common among patients with hyperthyroidism, and Graves' disease constitutes the most common cause of thyrotoxicosis.

Case Presentation: We report the case of a female patient admitted to the cardiology department with shortness of breath and pretibial myxedema. The diagnostic work-up revealed combined pre- and post-capillary pulmonary hypertension due to Graves' disease superimposed on left ventricular diastolic dysfunction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5812/cardiovascmed.30549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746995PMC
February 2016
33 Reads

Efficacy of Trimodality Therapy for Pretibial Myxoedema: A Case Series of 20 Patients.

Acta Derm Venereol 2016 06;96(5):714-5

Department of Dermatology, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, 200025 Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-2342DOI Listing
June 2016
20 Reads

Case report of Graves' disease manifesting with odynophagia and heartburn.

World J Gastroenterol 2015 Dec;21(48):13582-6

Yulia Evsyutina, Alexander Trukhmanov, Vladimir Ivashkin, Olga Storonova, Department of Internal Disease Propaedeutics, Gastroenterology and Hepatology, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

Graves' disease is an autoimmune disease, which can manifest with a variety of extrathyroidal clinical syndromes like ophthalmopathy, pretibial myxedema (dermopathy), acropathy, cardiomyopathy, and encephalopathy. Though quite rare, this disease can also manifest with gastrointestinal symptoms such as dysphagia, heartburn, nausea, vomiting and diarrhea. We report a clinical case of Graves' disease manifesting with dysfunction of the esophagus and heartburn in a 61-year-old man. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i48.13582DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690189PMC
December 2015
62 Reads

Dermoscopy of pretibial myxedema.

J Am Acad Dermatol 2015 Dec;73(6):e195-6

Department of Dermatology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01909622150198
Publisher Site
http://dx.doi.org/10.1016/j.jaad.2015.07.035DOI Listing
December 2015
30 Reads

A Randomized Controlled Trial of Intralesional Glucocorticoid for Treating Pretibial Myxedema.

J Clin Med Res 2015 Nov 25;7(11):862-72. Epub 2015 Sep 25.

Department of Dermatology, China National Nuclear Corporation 416 Hospital, No.4, Er Huan Lu Bei Si Duan, Chengdu City, Sichuan Province, China.

Background: Pretibial myxedema (PTM) is an uncommon dermopathy associated with autoimmune thyroid diseases. Now it is thought to be autoimmune and its treatment with glucocorticoid is helpful. However, it has not been evaluated. Read More

View Article

Download full-text PDF

Source
http://www.jocmr.org/index.php/JOCMR/article/view/2303
Publisher Site
http://dx.doi.org/10.14740/jocmr2303wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596268PMC
November 2015
37 Reads

Pre-tibial myxedema: treatment with intralesional corticosteroid.

An Bras Dermatol 2015 May-Jun;90(3 Suppl 1):143-6

Universidade Federal do Amazonas, Manaus, AM, BR.

The pretibial myxedema is a manifestation of Graves' disease characterized by accumulation of glycosaminoglycans in the reticular dermis. The dermopathy is self-limiting but in some cases may cause cosmetic and functional damage. Conventional treatment is use of topical steroids under occlusive dressing, however the intralesional application has shown good results. Read More

View Article

Download full-text PDF

Source
http://www.scielo.br/pdf/abd/v90n3s1/0365-0596-abd-90-03-s1-
Web Search
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S
Publisher Site
http://dx.doi.org/10.1590/abd1806-4841.20153651DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540532PMC
January 2016
19 Reads

Pretibial myxedema.

QJM 2015 Dec 31;108(12):985. Epub 2015 Jul 31.

Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, 605 006, India. email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/qjmed/hcv136DOI Listing
December 2015
40 Reads

Radiation therapy as part of the therapeutic regimen for extensive multilocular myxedema in a patient with exophthalmos, myxedema and osteoarthropathy syndrome: A case report.

Oncol Lett 2015 May 26;9(5):2404-2408. Epub 2015 Feb 26.

Department of Radiation Oncology, University Hospital of Muenster, Muenster D-48149, Germany.

Exophthalmos, myxedema and osteoarthropathy (EMO) comprise the triad known as EMO syndrome, which is rarely observed in patients with autoimmune thyroid disease. The present study reports the case of a patient with EMO, including the response of this rare combination to radiotherapy. A 48-year-old patient with EMO syndrome presented to the Department of Radiation Oncology, University Hospital of Muenster, eight years prior to writing with therapy-resistant pretibial myxedema and hypertrophic osteoarthropathy of the metacarpal bones. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2015.2990DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467320PMC
May 2015
26 Reads

Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.

Int J Dermatol 2015 Aug 27;54(8):e280-6. Epub 2015 May 27.

Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Introduction: Pretibial myxedema (PTM) is a rare manifestation of Graves' disease. There is paucity of data regarding long-term follow-up and response to treatment in PTM.

Materials And Methods: Retrospective study wherein 30 patients of PTM presenting during 2001-2011 attending dermatology and endocrinology outpatient departments were analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.12658DOI Listing
August 2015
19 Reads

Dramatic effect of low-dose oral steroid on elephantiasic pretibial myxedema.

J Dermatol 2014 Oct 9;41(10):941-2. Epub 2014 Sep 9.

Department of Dermatology, Tokyo Medical University, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.12608DOI Listing
October 2014
30 Reads

Pretibial myxedema.

Cutis 2014 Aug;94(2):60, 73-4

University of Iowa Hospitals and Clinics, Department of Dermatology, 200 Hawkins Dr, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
August 2014
17 Reads

Pretibial Myxedema Associated with Euthyroid Hashimoto's Thyroiditis: A Case Report.

J Clin Diagn Res 2014 Jun 20;8(6):YD01-2. Epub 2014 Jun 20.

Resident, Department of Dermatology and Venereology, Pramukhswami Medical College , Karamsad, Anand, Gujarat, India .

Pretibial myxedema (PM) is an infiltrative dermopathy which is seen in grave's disease. It is also associated with hypothyroidism, but is infrequently seen in Hashimoto's thyroiditis. Lesions are seen commonly over pretibial region as non-pitting oedema or with a plaque morphology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7860/JCDR/2014/6581.4415DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129354PMC
June 2014
20 Reads

Extrathyroidal manifestations of Graves' disease: a 2014 update.

J Endocrinol Invest 2014 Aug 10;37(8):691-700. Epub 2014 Jun 10.

Department of Endocrinology and Metabolism, Mayo Clinic, Rochester, MN, USA.

Introduction: Graves' orbitopathy (GO), thyroid dermopathy (also called pretibial myxedema) and acropachy are the extrathyroidal manifestations of Graves' disease. They occur in 25, 1.5, and 0. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s40618-014-0097
Web Search
http://link.springer.com/10.1007/s40618-014-0097-2
Publisher Site
http://dx.doi.org/10.1007/s40618-014-0097-2DOI Listing
August 2014
41 Reads

Elephantiasic pretibial myxedema in a patient with graves disease that resolved after 131I treatment.

Clin Nucl Med 2014 Aug;39(8):758-9

From the Departments of *Emergency Medicine, and †Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Pretibial myxedema is a rare manifestation of Graves disease and is generally associated with ophthalmopathy. Steroids, immunoglobulin, or rituximab can have some therapeutic effect but not curative. Here we reported a 45-year-old man with history of hyperthyroidism for 20 years who developed severe bilateral pretibial myxedema. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000459DOI Listing
August 2014
24 Reads